Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Nacuity Pharmaceuticals Announces Expansion of its Business Advisory Board with Appointment of Rare Disease Advocate Daniel Feller [Yahoo! Finance]

BPOST SA UNSP/ADR (BPOSY) 
NASDAQ:AMEX Investor Relations: corporate.bpost.be/investors?sc_lang=en
Company Research Source: Yahoo! Finance
for retinitis pigmentosa, cataracts and other ocular diseases caused by oxidative stress, today announced the expansion of its business advisory board with the appointment of Daniel Feller. Mr. Feller founded Talisman Licensing, a brand building agency in Melbourne, Australia, and has served as its CEO since the Company's inception in 2007. He also currently serves as Chief Operations Officer at GEM42S Ltd, a pioneering biotechnology company dedicated to the development of cutting-edge therapies using Base Editing and CRISPR techniques to treat rare diseases and advance towards addressing major diseases. Founded on the principle of leveraging innovative genomic technologies, GEM42S Ltd is committed to revolutionizing the landscape of medicine by targeting the root causes of genetic disorders. After their son was born afflicted with Usher syndrome 1F, Mr. Feller and his wife, Hollie Feller, co-founded Genetic Cures Australia to support the growth of medical research on gene-based a Show less Read more
Impact Snapshot
Event Time:
BPOSY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BPOSY alerts
Opt-in for
BPOSY alerts

from News Quantified
Opt-in for
BPOSY alerts

from News Quantified